NCT01331135 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01331135
Title	Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
Acronym	Aflac ST0901
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Emory University
Indications	Ewing sarcoma clear cell sarcoma nephroblastoma neuroblastoma renal cell carcinoma retinoblastoma malignant astrocytoma high grade glioma rhabdoid cancer medulloblastoma osteosarcoma atypical teratoid rhabdoid tumor germ cell cancer high grade ependymoma hepatoblastoma rhabdomyosarcoma
Therapies	Sirolimus
Age Groups:	adult \| child
Covered Countries	USA

NCT01331135
Clinical Trial Detail